Programs
- Resistance Networks
- Focused Antibiotics
- VISIBLE
- FORM
- The Missed Vital Sign
- CARE
- Untangling Addiction
- Dynamic Resilience
- Q4Bio
- SAVE
- In Utero
- R3 Global
- MCPsych
- Delta Tissue
- 1kD
- HOPE
Women’s Health
Team
News
Stories

Home » CARE – Open Enrollment & Listing Opportunities » CARE_ Open Enrollment & Listing Opportunities (Feb 2026)

CARE_ Open Enrollment & Listing Opportunities (Feb 2026)

by ashortsleeves
June 16, 2026

Search for...

Recent Posts

Opinion: It’s time. Women have waited long enough
Melinda French Gates & Regina Dugan Announce $100 Million Partnership To Advance Women’s Health
Melinda French Gates Backs $100 Million Bet On Women’s Health Breakthroughs
Time to ‘stop tolerating women’s pain and suffering’: Melinda Gates-backed research initiative raises $100M
Practicing Innovation as a Discipline

Recent Comments

Archives

October 2025
September 2025
August 2025
June 2025
May 2025
April 2025

Categories

2025 Forbes Power Women's Summit
Aspen Ideas Festival
Aspen Ideas Health
BioWorld
Bloomberg
Devex
Engineering & Technology
Exponential View with Azeem Azhar
Fact Sheet
Fierce Biotech
Financial Times
Forbes
Fortune
Gamechangers from The Economist
Issues in Science and Technology
New York Times
Press Release
Research Professional News
Schmidt Futures
Take on Tomorrow
The Minor Consult podcast
The Washington Post
Unbiased Science podcast
ZEIT für Forschung

Meta

Log in
Entries feed
Comments feed
WordPress.org

Recent Posts

Opinion: It’s time. Women have waited long enough
Melinda French Gates & Regina Dugan Announce $100 Million Partnership To Advance Women’s Health
Melinda French Gates Backs $100 Million Bet On Women’s Health Breakthroughs
Time to ‘stop tolerating women’s pain and suffering’: Melinda Gates-backed research initiative raises $100M
Practicing Innovation as a Discipline

Recent Comments

© 2022 Wellcome Leap Inc. All Rights Reserved.

© 2022 Wellcome Leap Inc. All Rights Reserved.

© 2026 Wellcome Leap Inc. All Rights Reserved.

Wellcome Leap is a 501(c)(3) organization.